1832P Centralized screening for homologous recombination repair (HRR) genes in metastatic castration-resistant prostate cancer (mCRPC): A feasibility study from a multicenter Spani... von Freire, J., Caramelo, B., Duran Martinez, I., del Carmen, S., Azueta, A., García-Berbel, P., Diaz, P.D., Cacho Lavin, D., Orellana, M., Lencina, M., Mordillo, C., Gómez, J.

Volltext

2366P Phase I-II study of niraparib plus cabozantinib in patients with advanced urothelial/kidney cancer (NICARAGUA trial) von Castellano Gauna, D.E., Duran Martinez, I., Mellado Gonzalez, B., Climent Duran, M.A., Garcia Del Muro, X., Sala González, N., Alonso Gordoa, T., Sevillano Fernandez, E., Domenech Santasusana, M., Paramio, J., Real, F.X., Malats, N., Font Pous, A.

Volltext

1779TiP Phase II clinical study evaluating the efficacy and safety of disitamab vedotin in patients (pts) with HER2-expressing urothelial carcinoma (RC48G001) von Koshkin, V.S., Powles, T.B., Iyer, G., Loriot, Y., Drakaki, A., Duran Martinez, I., De Santis, M., Retz, M., Jain, R.K., Chan, S., Ichimaru, M., Galsky, M.D.

Volltext

2382P EBANO study: Clinical characteristics, treatment patterns and survival results in patients with locally advanced/metastatic urothelial carcinoma (la/mUC) in northern Spain von Fernandez-Rodriguez, R., Sagastibelza, N., Pujol Obis, E., Lainez Milagro, N., Sánchez-Escribano, R., Martinez Kareaga, M., Verdun Aguilar, J.A., Arruti Ibarbia, M., Pumares Gonzalez, M., De Portugal Fernandez del Rivero, T., Lacalle, A., Gil Arnaiz, I., Pereira-Elorrieta, A., Duran Martinez, I.

Volltext

1450MO Efficacy of a tailored approach with nivolumab and nivolumab/ipilimumab as immunotherapeutic boost in metastatic renal cell carcinoma: Final results of TITAN-RCC von Grimm, M-O., Esteban Gonzalez, E., Barthelemy, P., Schmidinger, M., Busch, J., Perez Valderrama, B., Charnley, N., Schmitz, M., Schumacher, U., Baretton, G., Duran Martinez, I., De Velasco Oria, G.A., Priou, F., Maroto Rey, J.P., Albiges, L.

Volltext

2393P Ephrin signalling mediates resistance to programmed death ligand 1 (PD-L1) inhibition in urothelial carcinoma (UC) von Yang, Y-H., Cubuk, C., Castellano Gauna, D.E., Banchereau, R., Kockx, M., Rodriguez-Vida, A., Duran Martinez, I., Crabb, S., van der Heijden, M.S., Font Pous, A., Gravis, G., Anido Herranz, U., Protheroe, A., Ravaud, A., Jackson-Spence, F., Toms, C., Mousa, K., Prendergast, A., Szabados, B.E., Powles, T.B.

Volltext

Tailored immunotherapy approach with nivolumab in advanced renal cell carcinoma (TITAN-RCC) von Grimm, M.-O., Schmidinger, M., Duran Martinez, I., Schinzari, G., Esteban, E., Schmitz, M., Schumacher, U., Baretton, G., Barthelemy, P., Melichar, B., Charnley, N., Schrijvers, D., Albiges, L.

Volltext

LBA57Tailored immunotherapy approach with nivolumab in advanced renal cell carcinoma (TITAN-RCC) von Grimm, M-O, Schmidinger, M, Duran Martinez, I, Schinzari, G, Esteban, E, Schmitz, M, Schumacher, U, Baretton, G, Barthelemy, P, Melichar, B, Charnley, N, Schrijvers, D, Albiges, L

Volltext

LBA57 - Tailored immunotherapy approach with nivolumab in advanced renal cell carcinoma (TITAN-RCC) von Grimm, M.-O., Schmidinger, M., Duran Martinez, I., Schinzari, G., Esteban, E., Schmitz, M., Schumacher, U., Baretton, G., Barthelemy, P., Melichar, B., Charnley, N., Schrijvers, D., Albiges, L.

Volltext

79P Pharmaceutical cost savings for the treatment of oncology patients in clinical trials von Gómez-Mediavilla, B., Leon, P. Lanza, Callejo, V. Martínez, Prieto, D. Cantarero, Postigo, M. Lanza, Sufrategui, M. Ochagavia, Lambea, M. Salcedo, Mesonero, Y. Blanco, Martinez, I. Duran, Cobo, C.M. Sarabia

Volltext

2623 Prospective validation of prognostic classifications in patients (pt) progressing to first-line chemotherapy in metastatic transitional-cell carcinoma (mTCC) von Arija, J.A. Arranz, Vazquez-Estevez, S, Perez-Valderrama, B, del Muro, X. Garcia, Laínez Milagro, N, Sala, N, Fita, M.J. Juan, Noguerón, E, Sáez, M.I, Rey, P. Maroto, Font, A, Díaz, E. Gallardo, Méndez-Vidal, M.J, Criado, M.P. Lopez, Quintela, M. Lázaro, Marin, A. Pinto, del Alba, A. Gonzalez, Caro, R. Luque, Lobera, C. Santander, Martínez, I. Duran

Volltext

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled... von Fizazi, Karim, Prof Dr, Scher, Howard I, Prof, Molina, Arturo, MD, Logothetis, Christopher J, Prof, Chi, Kim N, MD, Jones, Robert J, PhD, Staffurth, John N, MD, North, Scott, MD, Vogelzang, Nicholas J, MD, Saad, Fred, Prof, Mainwaring, Paul, MD, Harland, Stephen, MD, Goodman, Oscar B, MD, Sternberg, Cora N, MD, Li, Jin Hui, PhD, Kheoh, Thian, PhD, Haqq, Christopher M, MD, de Bono, Johann S, Prof

Volltext

Malignant mesothelioma of tunica vaginalis von Stradella, A, Conde-Gallego, E, Escalera-Almendros, C.A, Durán-Martínez, I

Volltext

Malignant mesothelioma of tunica vaginalis von Stradella, A, Conde-Gallego, E, Escalera-Almendros, C A, Durán-Martínez, I

Volltext

Connected Insulin Pens and Caps: An Expert’s Recommendation from the Area of Diabetes of the Spanish Endocrinology and Nutrition Society (SEEN) von Tejera-Pérez, Cristina, Chico, Ana, Azriel-Mira, Sharona, Lardiés-Sánchez, Beatriz, Gomez-Peralta, Fernando

Volltext

Mesotelioma maligno de túnica vaginal von Stradella, A, Conde-Gallego, E, Escalera-Almendros, C.A, Durán-Martínez, I

Volltext

Malignant mesothelioma of tunica vaginalis von Stradella, A, Conde-Gallego, E, Escalera-Almendros, C A, Durán-Martínez, I

Volltext

Propuesta de actividades para la introducción de la lengua inglesa en Educación Infantil a través de centros de interés basados en el arte von Velasco Martín, Lara

Volltext bestellen

To Kill and Tell? State Power, Criminal Competition, and Drug Violence von Duran-Martinez, Angelica

Volltext

Hacia una nueva perspectiva en el proceso de aprendizaje integrado de contenidos y lengua (CLIL) : los cuentos como recurso didáctico en el área de science von Cimarras Rivas, María

Volltext bestellen